lifestyle.careersavvy.co.uk

Author: DAEWOONG PHARMACEUTICAL

CGBIO Receives FDA 510(k) Clearance for Patient-Specific Titanium Implant ‘EASYMADE TI’

April 24, 2026
Daewoong Pharmaceutical Hosts ‘NABOTA Master Class’… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments

April 24, 2026
CGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results

April 7, 2026
CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: “Smaller Incisions, Faster Recovery”

March 30, 2026